Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on therapy for osteoporosis.

Angelo A Licata1

  • 1Department of Endocrinology, Center for Space Medicine, Metabolic Bone Center, Cleveland Clinic, Cleveland, OH, USA.

Orthopedic Nursing
|June 1, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DXA and clinical challenges of fracture risk assessment in primary care.

Cleveland Clinic journal of medicine·2021
Same author

History of etidronate.

Bone·2020
Same author

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE QUALITY OF DXA SCANS AND REPORTS.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2018
Same author

Corrigendum to "Low Body Mass Index Can Identify Majority of Osteoporotic Inflammatory Bowel Disease Patients Missed by Current Guidelines".

TheScientificWorldJournal·2017
Same author

Replacement of daily load attenuates but does not prevent changes to the musculoskeletal system during bed rest.

Bone reports·2017
Same author

Challenges of Estimating Fracture Risk with DXA: Changing Concepts About Bone Strength and Bone Density.

Aerospace medicine and human performance·2015
Same journal

Radiology Case Review: Multiple Myeloma.

Orthopedic nursing·2026
Same journal

Enhanced Recovery Nursing for Delirium and Functional Recovery After Femoral Neck Fracture Surgery in Older Adults.

Orthopedic nursing·2026
Same journal

Walking the Tight Rope for a Diagnosis: A Case Report of a Dermatological Enigma of Surgical Device Nickel Allergy.

Orthopedic nursing·2026
Same journal

Determining the Appropriate Pharmaceutical Prophylaxis for Venous Thromboembolism Following Total Joint Arthroplasty: A Systematic Literature Review.

Orthopedic nursing·2026
Same journal

Naon Announcements.

Orthopedic nursing·2026
Same journal

Some Nursing History and an Ode to Nursing.

Orthopedic nursing·2026
See all related articles

Recent osteoporosis treatments offer new options for women, including antiresorptive drugs and anabolic agents like teriparatide. These therapies improve bone density and quality, addressing adherence challenges and offering hope for bone reconstitution.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Bone Biology

Background:

  • Osteoporosis treatment has evolved significantly due to advances in skeletal metabolism.
  • Antiresorptive drugs, the oldest class, demonstrate broader effects beyond bone density.
  • Patient adherence remains a challenge in long-term osteoporosis management.

Purpose of the Study:

  • To review historical and recent advancements in osteoporosis pharmacotherapy.
  • To highlight novel therapeutic agents and their mechanisms of action.
  • To discuss the physiological impact of new osteoporosis drugs on bone quality.

Main Methods:

  • Review of current literature on osteoporosis pharmacotherapy.
  • Analysis of the mechanisms of action for antiresorptive and anabolic agents.

Related Experiment Videos

  • Comparison of therapeutic outcomes and patient adherence.

    • Main Results:

    • New bisphosphonates improve patient adherence to osteoporosis therapy.
    • Anabolic agents, such as teriparatide, can rebuild bone structure.
    • Understanding drug actions on bone quality offers new therapeutic insights.

    Conclusions:

    • Pharmacological options for osteoporosis have expanded, offering improved bone health.
    • Novel anabolic agents hold promise for bone regeneration in osteoporosis patients.
    • This review provides an updated perspective on skeletal physiology and osteoporosis treatment.